MYC and cancer: Furthermore, our results clearly show that tumor sphere formation ability, CD133+ cancer cell population, and the expression level of stem cell markers (Nanog, c-Myc and TLF4) were significantly reduced by both NLK knockdown and metformin treatment, indicating NLK may be responsible for the inhibition of cancer cell self-renewal and stemness achieved by metformin.